# MarketFlow Improved Evidence Planning Execution Using Redesigned Evidence Status

## Execution

- Artifact: `IMPROVED_EVIDENCE_PLANNING_EXECUTED_USING_REDESIGNED_EVIDENCE`.
- Status: `IMPROVED_EVIDENCE_PLANNING_EXECUTED_USING_REDESIGNED_EVIDENCE_RESEARCH_ONLY`.
- Execution digest: `1f2f04133a6b1d80dd30b5e8b4af08f1ae78aca8a164aa7a760a693192a894a4`.
- Run timestamp: `2026-08-22T07:40:13.414995Z`.
- Classification/scope: `COMPLETED_RESEARCH_ONLY` / `PLANNING_EXECUTION_ONLY_NOT_EVIDENCE_EXECUTION`.
- Checklist: `32 / 32` passed, `0` failed, `0` blockers.

## Source Approval

- Approval digest: `6aad4b27a57310b59c33e3ecfc93754df7da815c3ea15d8e686f8fe73abef664`.
- Candidate review/candidate digests: `d69cf64437f1dbd69a929e00c94a6cc9c13e6148102cd2adc91d1ed4eff8ceb6` / `bfda433e36eb6d333dcc2169d8d18bb31ab0671403cc6d447dc1eda0b10fd72b`.
- All redesign, target-definition, path, readiness, reassessment, predictive-evidence, matrix, feature, label, registry, and records digests remain exactly bound.
- All 23 required source files were present; large-file SHA-256 values and redesign/review manifest bindings matched; source files remained unchanged.

## Dataset And Universe

- Dataset: `expanded_universe_canonical_dataset_v1`; `RTH_FULL_SESSION_1D`; `1d`; `2022-01-01` through `2025-12-31`; `11946` records.
- Exact order: MSFT, NVDA, AMZN, GOOGL, META, TSLA, JPM, XOM, JNJ, WMT, CAT, LMT.
- META remains exactly `913`; every other ticker remains exactly `1003`.
- All 12 per-ticker execution entries are `EXECUTED_RESEARCH_ONLY`, carry deterministic execution digests, and preserve every downstream authority boundary. META retains `PRESERVE_META_LIMITATION_IN_IMPROVED_EVIDENCE_PLANNING_EXECUTION`.

## Planning Execution Policy

The execution performed research-only planning: it defined review structures, analysis plans, validation policies, controls, and an operator summary. It did not perform the evidence work those plans describe. Every plan remains `PLANNED_REQUIRES_RESULTS_REVIEW`.

## Planning Facts

- Selected direction: `REDESIGN_OPTION_ADD_OR_FORMALIZE_NO_TRADE_ABSTAIN_CLASS`.
- The completed research-only source findings and operator-selection requirements remain unchanged.
- FLAT remains the largest aggregated class at `13600`; NO_TRADE remains `1540`; evaluated OOS rows remain `34848`.
- Preserved accuracy facts: majority/local `0.58626033`, cross-sectional `0.58935950`, and cross-sectional delta `0.00309917`.
- Preserved five-session thresholds: global `0.026556108631` and benchmark-relative `0.02058653801`.
- `NO_LABEL_REGENERATION_OR_NEW_TARGETS_AUTHORIZED` remains the source redesign decision.

## Proposed Label Schema Plan

Defines future review of directional and no-trade/abstain semantics, eligibility questions, and schema-review acceptance questions. It creates no label values, target rows, or target-definition authority.

## No-Trade / Abstain Coverage Plan

Defines future coverage review by ticker and horizon, abstention eligibility review, and class-balance decision questions. It preserves the source FLAT, NO_TRADE, and OOS counts and computes no new metric.

## Material-Move Threshold Plan

Defines future sensitivity and policy questions around the preserved global and benchmark-relative thresholds. It selects no threshold and creates no target.

## Horizon-Specific Validation Plan

Defines separate chronological review of the source 5-, 10-, and 20-session horizons, with embargo and coverage-stability requirements. It performs no validation run.

## Ticker / Regime Split Validation Plan

Defines future per-ticker coverage and regime-review dimensions without creating split or regime targets. META's 913-row limitation remains a separately reported constraint.

## Feature-Label Alignment Plan

Defines future timestamp, identity, missingness, horizon-compatibility, and no-peek checks over the frozen label, feature, and matrix bindings. It generates no feature values or matrix rows.

## Chronological Split And Embargo Plan

Prohibits random time shuffling and defines future separation of training, validation, and OOS periods. Embargo selection remains future results-review input rather than an executed split.

## Baseline And Model Comparison Plan

Preserves majority, local, and cross-sectional comparison facts and requires a future materiality review. It recomputes no metric and trains no model.

## Calibration / Brier Plan

Defines future probability-calibration, Brier-reporting, and ticker/horizon stability questions. No calibration or Brier metric was computed.

## Leakage And No-Peek Control Plan

Defines future feature-timing, chronological-boundary, embargo, identity-isolation, and digest controls. It does not execute evidence or mutate a frozen source.

## Per-Ticker And META Reporting Plan

Defines exact-order reporting for all 12 tickers, separate aggregate/per-ticker limitations, and explicit META reporting without repair, inference, normalization, or fabrication.

## Output Digest Manifest

- Exactly 14 sanitized outputs were written under ignored `.marketflow/improved_evidence_planning_using_redesigned_evidence/expanded_universe_v1/`.
- Thirteen non-self outputs have file SHA-256 digests. The digest manifest uses `SELF_REFERENTIAL_DIGEST_NOT_APPLICABLE` with a null self digest and an explicit binding digest.
- Generated `.marketflow` outputs are runtime evidence, not source, and are not tracked.

## Authority Boundary

- Planning execution and planning-results creation are true; planning-results review remains false and future.
- Label regeneration, new-target creation, target-definition change authorization, feature generation, and feature-label matrix creation remain false.
- No additional predictive-evidence execution candidate or predictive execution was created.
- Predictive usefulness and profitability remain `not accepted`; acceptance readiness and candidacy remain false.
- Runtime, strategy, paper trading, broker execution, scoring, recommendations, and trading remain `NOT_AUTHORIZED`.
- No provider call, live transport, market-data acquisition, dataset regeneration, source mutation, metric recomputation, model training, runtime action, or trading action occurred.

## Follow-On Results Review

`Optional Improved Evidence Planning Results Review Using Redesigned Evidence v1` is implemented as a separate offline, digest-bound review. This execution remains its read-only source evidence.

- The results review does not regenerate labels or create targets.
- It does not generate features or create feature-label matrix rows.
- It does not create an additional predictive-evidence execution candidate or execute evidence.
- It does not accept predictive usefulness, approve profitability, or authorize runtime.

## Next Gate

The next possible gate is an optional additional predictive-evidence execution candidate using improved evidence, only if separately selected. Neither this execution nor its results review creates that candidate or authorizes any acceptance, profitability, runtime, or trading step.
